Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 14, 2024

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions

Advanced Solid Tumor

Interventions

DRUG

HRS-1167 tablets; rifampicin

HRS-1167 tablets single oral dose of HRS-1167 or co-administered with rifampicin.

Trial Locations (1)

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06198556 - Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects | Biotech Hunter | Biotech Hunter